| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | 
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Total Revenue | 113.21B | 121.00B | 106.12B | 158.81B | 318.98B | 277.07B | 
| Gross Profit | 113.21B | 121.00B | 123.32B | 104.86B | 316.11B | 271.14B | 
| EBITDA | 16.99B | 23.73B | 19.85B | 12.65B | 16.75B | 17.50B | 
| Net Income | 9.17B | 8.43B | 5.37B | 4.30B | 7.51B | 6.55B | 
| Balance Sheet | ||||||
| Total Assets | 1.87T | 1.73T | 1.51T | 1.41T | 1.38T | 1.17T | 
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 44.39B | 42.55B | 308.46B | 293.80B | 266.36B | 
| Total Debt | 33.28B | 82.12B | 101.43B | 117.05B | 95.17B | 61.27B | 
| Total Liabilities | 1.74T | 1.61T | 1.38T | 1.31T | 1.27T | 1.05T | 
| Stockholders Equity | 90.23B | 87.07B | 78.99B | 75.51B | 88.07B | 90.65B | 
| Cash Flow | ||||||
| Free Cash Flow | 97.21B | 116.24B | 127.67B | 88.72B | 94.48B | 110.33B | 
| Operating Cash Flow | 106.92B | 125.95B | 134.60B | 95.02B | 98.63B | 114.20B | 
| Investing Cash Flow | -158.04B | -95.63B | -130.95B | -80.30B | -99.62B | -110.85B | 
| Financing Cash Flow | 9.76B | -27.91B | 19.79B | -9.76B | 9.06B | -945.65M | 
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth | 
|---|---|---|---|---|---|---|---|
| ― | $1.14T | 5.48 | 21.57% | 3.85% | 17.69% | 126.41% | |
| ― | HK$202.89B | 4.73 | 34.37% | 5.37% | 49.90% | 203.77% | |
| ― | $61.03B | 7.47 | 10.74% | 2.01% | 23.64% | 36.32% | |
| ― | $1.08T | 7.77 | 12.80% | 4.99% | 12.05% | 32.41% | |
| ― | $744.16B | 16.26 | 15.16% | 2.41% | 5.65% | 30.47% | |
| ― | $361.60B | 5.88 | 17.37% | 3.60% | 13.82% | 39.75% | |
| ― | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | 
China Taiping Insurance Holdings Co has announced the appointment of Ms. NA Yanfang as an executive director and a member of several key committees, effective September 25, 2025. This strategic move is expected to enhance the company’s governance and operational efficiency, potentially strengthening its position in the competitive insurance market.
The most recent analyst rating on (HK:0966) stock is a Sell with a HK$9.40 price target. To see the full list of analyst forecasts on China Taiping Insurance Holdings Co stock, see the HK:0966 Stock Forecast page.
China Taiping Insurance Holdings Co has announced the composition of its board of directors and their roles within the company. The board includes executive, non-executive, and independent non-executive directors, with specific members assigned to various committees such as Audit, Nomination and Remuneration, Risk Management, and Strategy and Investment. This announcement highlights the company’s governance structure, which is crucial for stakeholders to understand the leadership and decision-making processes within the organization.
The most recent analyst rating on (HK:0966) stock is a Sell with a HK$9.40 price target. To see the full list of analyst forecasts on China Taiping Insurance Holdings Co stock, see the HK:0966 Stock Forecast page.
China Taiping Insurance Holdings Co, a prominent player in the insurance sector, operates across life, property, and casualty insurance, as well as asset management, with a strong presence in Hong Kong, Macau, and Mainland China.
China Taiping Insurance Holdings reported a robust financial performance for the first half of 2025, with a 12.2% increase in profit attributable to owners, reaching HK$6.764 billion. The company saw significant growth across its life insurance, property and casualty, and reinsurance segments, driven by enhanced insurance service results and strategic initiatives. The company’s total equity and assets also saw substantial increases, reflecting strong investment activities and strategic capital management.
The most recent analyst rating on (HK:0966) stock is a Sell with a HK$11.80 price target. To see the full list of analyst forecasts on China Taiping Insurance Holdings Co stock, see the HK:0966 Stock Forecast page.
China Taiping Insurance Holdings Company Limited has announced a board meeting scheduled for 28 August 2025 to consider and approve the interim results for the first half of 2025. This meeting is significant as it will address the company’s financial performance and potentially impact its strategic direction, influencing stakeholders’ expectations.
The most recent analyst rating on (HK:0966) stock is a Hold with a HK$12.00 price target. To see the full list of analyst forecasts on China Taiping Insurance Holdings Co stock, see the HK:0966 Stock Forecast page.